孚能科技(688567.SH):第二代半固態電池預計在下半年量產
格隆匯5月23日丨孚能科技(688567.SH)在投資者互動平臺表示,公司固態電池商業化進展領先,固態電池出貨量位居行業排名前列。第一代半固態電池已於2022年量產裝車;第二代半固態電池預計在下半年量產,將率先應用在低空經濟、人形機器人等高價值量場景,有望進一步提振固態電池產品收入。在客戶合作方面,公司固態電池產品已獲得廣汽、東風、三一、一汽解放、美國頭部eVTOL客戶、國內頭部飛行汽車客戶、上海時的、吉利沃飛等多領域頭部客戶的認可。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.